ReviewaBIOTECH2025
Agricultural biotechnology in China: product development, commercialization, and perspectives.
Review in aBIOTECH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- From lab to market: industrialization barriers and regulation optimization for new breeding technologies in China.GM crops & food · 2026Article
- Metabolic engineering of cereal lipids: from omega-3 fatty acids to wax esters and pheromones.Advanced biotechnology · 2026Review
- Article
- Bibliometric-Based Analysis of Global Trends and Collaborative Networks in Plant Genetic Engineering (1994-2024).Plant biotechnology journal · 2026Review
- Beyond GMOs: transgene-free gene-edited crops for global food security.Frontiers in plant science · 2026Review
- Methods Established forPlants (Basel, Switzerland) · 2025Article
- CRISPR activation: identifying and using novel genes for plant disease resistance breeding.Frontiers in genome editing · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meeting the increasing demand for food and industrial products by the growing global population requires targeted efforts to improve crops, livestock, and microorganisms. Modern biotechnology, particularly genetic modification (GM) and genome-editing (GE) technologies, is crucial for food security and environmental sustainability. China, which is at the forefront of global biotechnological innovation and the rapid advancements in GM and GE technologies, has prioritized this field by implementing strategic programs such as the National High-tech Research & Development Program in 1986, the National Genetically Modified Organism New Variety Breeding Program in 2008, and the Biological Breeding-National Science and Technology Major Project in 2022. Many biotechnological products have been widely commercialized in China, including biofertilizers, animal feed, animal vaccines, pesticides, and GM crops such as cotton (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.